Evidence map›Paper›PMID 31263220›Full record

ReviewNature reviews. Molecular cell biology2019

DNA double-strand break repair-pathway choice in somatic mammalian cells.

Ralph Scully, Arvind Panday, Rajula Elango, Nicholas A Willis

Abstract readReview
In one paragraph

Review in Nature reviews. Molecular cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 885 papers.

0numbers the graph read from it
0cells of the map it votes in
885citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

885 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Deciphering the phenotypic responses toEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Repair of DNA double-strand breaks after low radiation doses in childhood cancer survivors and matched cancer-free individuals.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Metabolic engineering ofApplied and environmental microbiology · 2026
    Review

825 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ralph ScullyDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. rscully@bidmc.harvard.edu.ORCID http://orcid.org/0000-0002-5064-0175
Arvind PandayDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Rajula ElangoDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Nicholas A WillisDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. nwillis@bidmc.harvard.edu.ORCID http://orcid.org/0000-0003-2091-5462

Funding

Tissue and Pathology CoreP50CA168504 · NCI · DANA-FARBER CANCER INST · PI Geoffrey I. Shapiro · 2013 to 2026
$30.1M
ANALYSIS OF BRCA1 RECOMBINATION FUNCTIONSR01CA095175 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2002 to 2021
$4.9M
FANCM in repair of stalled replication forksR01CA217991 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2017 to 2021
$2.0M
Regulation of stalled fork repair in mammalian cellsR01GM134425 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2019 to 2022
$1.4M
Replication fork collapse in mammalian cellsR21ES027776 · NIEHS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2017 to 2018
$476k
Investigating DNA repair vulnerabilities in oncometabolite producing cancersF31CA260794 · NCI · YALE UNIVERSITY · PI NORONHA, KATELYN · 2021 to 2023
$122k
NCI NIH HHS F31 CA260794NCI NIH HHS P50 CA168504NCI NIH HHS R01 CA095175NCI NIH HHS R01 CA217991NIEHS NIH HHS R21 ES027776NIGMS NIH HHS R01 GM134425
6 · The paper itself

Abstract

The major pathways of DNA double-strand break (DSB) repair are crucial for maintaining genomic stability. However, if deployed in an inappropriate cellular context, these same repair functions can mediate chromosome rearrangements that underlie various human diseases, ranging from developmental disorders to cancer. The two major mechanisms of DSB repair in mammalian cells are non-homologous end joining (NHEJ) and homologous recombination. In this Review, we consider DSB repair-pathway choice in somatic mammalian cells as a series of 'decision trees', and explore how defective pathway choice can lead to genomic instability. Stalled, collapsed or broken DNA replication forks present a distinctive challenge to the DSB repair system. Emerging evidence suggests that the 'rules' governing repair-pathway choice at stalled replication forks differ from those at replication-independent DSBs.

Indexed as

DNA Breaks, Double-StrandedDNA End-Joining RepairDNA ReplicationGenomic InstabilityAnimalsHumans

Identifiers

PMID31263220
PMCPMC7315405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.